Paclitaxel Soft Capsules(Meiji Biopharma)

紫杉醇软胶囊(美济生物医药)

Report date: 2025/10/27 15:10:13

Base Information

Drug NamePaclitaxel Soft Capsules(Meiji Biopharma)
Drug Alias Name浆果赤霉素III太平洋紫杉醇紫杉醇白蛋白
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation promotersTubulin depolymerization inhibitors
TargetsTubulin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A